✦ LIBER ✦

Citalopram is effective in obsessive compulsive disorder: Results of a double-blind, placebo-controlled trial

✍ Scribed by S. Kasper; I.D. Note; S. Montgomery

Book ID: 118601302
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 272 KB
Volume: 9
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(99)80138-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A double-blind, placebo-controlled trial

A double-blind, placebo-controlled trial of olanzapine addition in fluoxetine-refractory obsessive-compulsive disorder

✍ Nathan A Shapira; Herbert E Ward; Miguel Mandoki; Tanya K Murphy; Mark C.K Yang; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 115 KB

P-6-12 A double-blind, placebo-controlle

P-6-12 A double-blind, placebo-controlled trial of fluoxetine in patients with obsessive-compulsive disorder in Austria

✍ K. Meszaros; W. Zitterl; M. Dossenbach; K. Zitterl-Eglseer; H. Klech 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 138 KB

P-6-10 A placebo controlled double blind

P-6-10 A placebo controlled double blind study in obsessive compulsive disorder with fluvoxamine

✍ Y. Kudo 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 272 KB

A double-blind, placebo-controlled pilot

A double-blind, placebo-controlled pilot study of ondansetron for patients with obsessive-compulsive disorder

✍ Farhad Soltani; Mehdi Sayyah; Fariba Feizy; Alireza Malayeri; Amir Siahpoosh; Is 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 1 views

## Abstract ## Objective To assess the efficacy and tolerability of ondansetron in combination with selective serotonin reuptake inhibitors (SSRIs) in patients with obsessive‐compulsive disorder (OCD). ## Methods The study was an 8‐week pilot double‐blind randomized clinical trial. Forty‐two adu

P.3.009 A double-blind, placebo-controll

P.3.009 A double-blind, placebo-controlled trial of folicacid addition in fluoxetine for treatment of obsessive-compulsive disorder

✍ Ü. Tural; A. Çorapçiolu; Ş. Bo¢gelmez; G. Körolu; C. Duman; E. Önder 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Low-dose risperidone augmentation of flu

Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study

✍ Stefano Erzegovesi; Emanuela Guglielmo; Francesca Siliprandi; Laura Bellodi 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 126 KB